[ABEO] Abeona Therapeutics Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 4.8 Change: 0.15 (3.23%)
Ext. hours: Change: 0 (0%)

chart ABEO

Refresh chart

Strongest Trends Summary For ABEO

ABEO is in the medium-term down -61% below S&P in 1 year. In the long-term up 80% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-400 K Cash From Investing Activities-10 K Cash From Operating Activities-3.16 M Gross Profit
Net Profit-2 M Operating Profit-2 M Total Assets13.12 M Total Current Assets8.19 M
Total Current Liabilities1.24 M Total Debt Total Liabilities9.96 M Total Revenue260 K
Technical Data
High 52 week21.45 Low 52 week6.38 Last close7.33 Last change13.29%
RSI45.3 Average true range0.42 Beta0.55 Volume171.07 K
Simple moving average 20 days8.37% Simple moving average 50 days5.55% Simple moving average 200 days-37.23%
Performance Data
Performance Week10.56% Performance Month6.08% Performance Quart-4.31% Performance Half-48.74%
Performance Year-45.09% Performance Year-to-date2.66% Volatility daily4.73% Volatility weekly10.57%
Volatility monthly21.67% Volatility yearly75.07% Relative Volume134.28% Average Volume552.97 K
New High New Low

News

2019-03-19 23:40:56 | Edited Transcript of ABEO earnings conference call or presentation 19-Mar-19 2:00pm GMT

2019-03-19 13:49:02 | Abeona Therapeutics Inc ABEO Q4 2018 Earnings Conference Call Transcript

2019-03-18 17:06:19 | Abeona Therapeutics: 4Q Earnings Snapshot

2019-03-18 16:45:00 | Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

2019-02-22 11:25:47 | What Investors Should Know About Abeona Therapeutics Inc.’s NASDAQ:ABEO Financial Strength

2019-02-22 08:01:00 | Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference

2019-02-13 08:15:00 | New Research: Key Drivers of Growth for WPX Energy, ACADIA Pharmaceuticals, Lexicon Pharmaceuticals, MobileIron, Arrow Electronics, and Abeona Therapeutics — Factors of Influence, Major Initiatives and Sustained Production

2019-02-11 16:05:00 | Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer

2019-02-01 07:30:00 | The Unknown Biotech Play that Could Deliver 400% Returns, or Much More

2019-01-31 08:00:00 | Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™

2019-01-08 13:00:00 | Abeona Therapeutics Strengthens Financial Leadership with New Executive Appointments

2018-12-25 06:24:45 | How Should Investors Feel About Abeona Therapeutics Inc.’s NASDAQ:ABEO CEO Pay?

2018-12-13 03:03:08 | Is Abeona Therapeutics Inc ABEO A Good Stock To Buy?

2018-12-11 08:52:01 | Abeona Therapeutics ABEO in Focus: Stock Moves 5.5% Higher

2018-12-10 08:44:01 | Why Abeona Therapeutics ABEO Could Be Positioned for a Slump

2018-12-06 12:30:00 | Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D Day

2018-12-03 08:27:01 | Moving Average Crossover Alert: Abeona Therapeutics

2018-11-29 08:45:00 | Abeona Therapeutics to Host R&D Day on December 6, 2018

2018-11-27 08:00:00 | Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results

2018-11-26 16:30:00 | Abeona Therapeutics Announces CEO Transition

2018-11-13 08:45:00 | Abeona Announces Participation at the Jefferies 2018 London Healthcare Conference

2018-11-13 07:26:19 | Edited Transcript of ABEO earnings conference call or presentation 12-Nov-18 3:00pm GMT

2018-11-09 17:35:10 | Abeona Therapeutics ABEO Reports Q3 Loss, Tops Revenue Estimates

2018-11-09 16:27:25 | Abeona Therapeutics: 3Q Earnings Snapshot

2018-11-09 16:20:00 | Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights

2018-11-07 11:18:24 | What Kind Of Share Price Volatility Should You Expect For Abeona Therapeutics Inc NASDAQ:ABEO?

2018-11-05 07:00:00 | REGENXBIO and Abeona Therapeutics Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector

2018-11-05 07:00:00 | Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector

2018-10-18 08:03:00 | Abeona Therapeutics Appoints João Siffert, M.D. Head of Research and Development and Chief Medical Officer

2018-10-16 07:55:00 | Investor Expectations to Drive Momentum within Cincinnati Bell, Hooker Furniture, AgroFresh Solutions, Forward Industries, Abeona Therapeutics, and Sientra — Discovering Underlying Factors of Influence

2018-09-28 13:45:47 | How Abeona Therapeutics Stock Is Doing

2018-09-28 08:45:00 | Abeona Announces Participation at Upcoming Conferences

2018-09-14 08:45:21 | When Will Abeona Therapeutics Inc NASDAQ:ABEO Become Profitable?

2018-09-13 14:03:48 | Analysts Still Bullish about BioLife Solutions

2018-09-12 08:45:00 | Abeona Therapeutics Announces Authorization to Commence Phase 1/2 Gene Therapy Clinical Study for Patients with MPS IIIB in Spain

2018-09-04 08:45:00 | Abeona Announces Participation at Upcoming Conferences

2018-08-17 07:50:00 | Factors of Influence in 2018, Key Indicators and Opportunity within AgroFresh Solutions, SMART SAND INC, Advantage Oil & Gas, Abeona Therapeutics, B. Riley Financial, and Audentes Therapeutics — New Research Emphasizes Economic Growth

2018-08-10 15:45:45 | Edited Transcript of ABEO earnings conference call or presentation 10-Aug-18 2:00pm GMT

2018-08-09 19:55:11 | Abeona Therapeutics ABEO Reports Q2 Loss, Lags Revenue Estimates

2018-08-09 18:50:46 | Abeona Therapeutics: 2Q Earnings Snapshot

2018-08-09 16:20:00 | Abeona Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights

2018-07-26 08:30:00 | Abeona Therapeutics Announces Leadership Appointments with Max Colao as Chief Commercial Officer

2018-07-11 10:17:02 | Implied Volatility Surging for Abeona Therapeutics ABEO Stock Options

2018-07-05 07:35:00 | Free Technical Reports on 22nd Century Group and Three Additional Biotech Equities

2018-06-18 16:21:00 | Newman Ferrara LLP Announces Corporate Governance Investigation of Abeona Therapeutics Inc. – ABEO

2018-06-07 07:47:00 | 57% Sales Growth, Top-Notch Partners At Overlooked Gene and Cell Therapy Issue ORGS

2018-06-06 08:45:00 | Abeona Therapeutics Announces Upcoming Presentation at Jefferies 2018 Global Healthcare Conference

2018-06-05 15:21:14 | Abeona Therapeutics Has First-Mover Potential In Rare Diseases, Seaport Says In Bullish Initiation

2018-06-05 07:20:00 | Free Technical Research on Versartis and Three More Biotech Equities

2018-06-04 14:30:00 | 9 Stocks Poised for Healthy Long-Term Gains